Lisa DeMarchi SleighLisaDeMarchi Sleigh

In the Matter of Danaher/General Electric – Reached an agreement whereby Danaher agreed to divest assets to settle FTC charges that its proposed $21.4 billion acquisition of General Electric’s biopharmaceutical business, GE Biopharma, would violate federal antitrust law.

FTC v. IQVIA Holdings and Propel Media – Litigated challenge to IQVIA’s proposed acquisition of Propel Media in the healthcare data and analytics space and was granted a preliminary injunction from the U.S. District Court for the Southern District of New York, after which the parties abandoned the transaction.

In the Matter of Lockheed Martin/Aerojet Rocketdyne Holdings – Challenged Lockheed’s proposed $4.4 billion acquisition of rocket-motor maker Aerojet Rocketdyne on defense-industry vertical foreclosure grounds; the parties abandoned the deal after the FTC sued to block it.

In the Matter of Fresenius Medical Care/NxStage Medical – Merger of two major hemodialysis-industry players — FTC approved a final consent order imposing divestiture conditions as a part of a settlement resolving charges that Fresenius’s proposed $2 billion acquisition to NxStage likely would be anticompetitive.

In the Matter of Otto Bock Healthcare North America – Litigated FTC challenge to a consummated acquisition in the prosthetics and orthotics device industry; granted Otto Bock’s application to divest its Freedom Innovations after an administrative law judge’s decision that the merger was anticompetitive.

DaVita dialysis-chain matters – Obtained consent order requiring the divestiture of 29 outpatient dialysis clinics around the United States, resolving FTC charges that DaVita’s proposed $689 million acquisition of CDSI I Holding Company (DSI) would be anticompetitive.

CentraCare Health''s purchase of St. Cloud Medical Group Minnesota – Reached a consent agreement allowing the two Minnesota healthcare providers to merge conditioned on one releasing some of its physicians from noncompete-contract clauses.